Condition
Metastatic Brain Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Metastatic Brain Tumor clinical trials that are recruiting, at sites in 8 countries (most in United States (5), Australia (3), Canada (3)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 8Countries
Newest Metastatic Brain Tumor clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Belvarafenib in BRAF-altered brain tumors | Phase 2 | Seoul | Recruiting | Jul 7, 2026 |
| Treatment of high-grade glioma in young patients using olutasidenib and temozolomide | Phase 2 | Aurora, Colorado and 19 other locations | Recruiting | Dec 8, 2023 |
| Combining ribociclib and everolimus for treating high-grade gliomas in young patients | Phase 2 | Aurora, Colorado and 19 other locations | Recruiting | May 6, 2023 |
| Genetic profiling for pediatric high-grade glioma treatment eligibility | — | Aurora, Colorado and 21 other locations | Recruiting | May 3, 2023 |
| New MRI technique to assess brain tumors after treatment | — | New York, New York | Recruiting | Sep 29, 2022 |
| Assessing brain function in patients with brain tumors | — | Omaha, Nebraska | Recruiting | Feb 17, 2012 |
All recruiting trials (6)
-
Belvarafenib in BRAF-altered brain tumors
This Phase 2 study tests Belvarafenib daily to see if it can help people with BRAF-altered primary or metastatic brain tumors.
-
Treatment of high-grade glioma in young patients using olutasidenib and temozolomide
This study is testing if a new combination of olutasidenib and temozolomide can help young patients with high-grade gliomas that have a specific mutation feel better after their radiotherapy.
-
Combining ribociclib and everolimus for treating high-grade gliomas in young patients
This study is testing if a combination of two drugs, ribociclib and everolimus, can help young patients with high-grade gliomas live longer and feel better after their initial treatment.
-
Genetic profiling for pediatric high-grade glioma treatment eligibility
This study is testing if genetic testing of brain tumors in children and young adults with high-grade gliomas can help match them to the best treatment options.
-
New MRI technique to assess brain tumors after treatment
This study is testing a new MRI method to see if it can tell the difference between real tumor growth and changes caused by treatment in people with brain tumors.
-
Assessing brain function in patients with brain tumors
This study is testing different brain imaging techniques to see how well they can help doctors understand brain function in patients with brain tumors before and after surgery.
Related topics
Quick answers
How many Metastatic Brain Tumor clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United States (5 trials), Australia (3 trials), Canada (3 trials), Germany (3 trials), New Zealand (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.